The estimated Net Worth of Amy Mc Bride Wendell is at least $4.36 Миллион dollars as of 1 September 2024. Ms. Wendell owns over 11,904 units of Baxter International stock worth over $4,040,844 and over the last 8 years she sold BAX stock worth over $0. In addition, she makes $322,547 as Independent Director at Baxter International.
Amy has made over 11 trades of the Baxter International stock since 2016, according to the Form 4 filled with the SEC. Most recently she exercised 11,904 units of BAX stock worth $467,470 on 1 September 2024.
The largest trade she's ever made was exercising 28,750 units of Baxter International stock on 12 May 2023 worth over $265,075. On average, Amy trades about 2,849 units every 74 days since 2016. As of 1 September 2024 she still owns at least 102,899 units of Baxter International stock.
You can see the complete history of Ms. Wendell stock trades at the bottom of the page.
Amy A. Wendell is the Indepedent Director of the Company. Ms. Wendell served as Senior Advisor at Perella Weinberg Partners L.P., a global financial services firm, consulting on strategy, corporate finance and investing practices in the healthcare industry from January 2016 to May 2019. From 2015 to September 2018, Ms. Wendell served as a Senior Advisor to McKinsey & Company, a management consulting firm, in its strategy and corporate finance practice and also served as a member of McKinsey’s transactions advisory board. She previously served as Senior Vice President of Strategy and Business Development and Licensing at Covidien from 2006 to 2015, where she led the company’s strategy and portfolio management initiatives and managed business development activities. From 1986 to 2015, Ms. Wendell held prior roles of increasing responsibility at Covidien (including its predecessors, Tyco International plc and Kendall Healthcare Products Company), from engineering to product management and business development. Ms. Wendell currently serves as a director of Axogen, Inc. and Hologic, Inc. She previously served as a director of EKSO Bionics Holdings, Inc.
As the Independent Director of Baxter International, the total compensation of Amy Wendell at Baxter International is $322,547. There are 17 executives at Baxter International getting paid more, with Jose Almeida having the highest compensation of $13,913,800.
Amy Wendell is 59, she's been the Independent Director of Baxter International since 2019. There are 10 older and 18 younger executives at Baxter International. The oldest executive at Baxter International Inc. is James Gavin, 74, who is the Independent Director.
Amy's mailing address filed with the SEC is C/O AXOGEN, INC. 13631 PROGRESS BLVD., SUITE 400, ALACHUA, FL, 32615.
Over the last 22 years, insiders at Baxter International have traded over $966,809,165 worth of Baxter International stock and bought 178,227 units worth $6,261,495 . The most active insiders traders include Point Llc Loeb Daniel S Third, Michael F Mahoney и Jeffrey A Craig. On average, Baxter International executives and independent directors trade stock every 37 days with the average trade being worth of $3,609,738. The most recent stock trade was executed by Jeanne K Mason on 1 March 2024, trading 64,488 units of BAX stock currently worth $2,397,019.
baxter provides a broad portfolio of essential renal and hospital products, including home, acute and in-center dialysis; sterile iv solutions; infusion systems and devices; parenteral nutrition; biosurgery products and anesthetics; and pharmacy automation, software and services. the company’s global footprint and the critical nature of its products and services play a key role in expanding access to healthcare in emerging and developed countries. baxter’s employees worldwide are building upon the company’s rich heritage of medical breakthroughs to advance the next generation of healthcare innovations that enable patient care.
Baxter International executives and other stock owners filed with the SEC include: